Chronic obstructive pulmonary disease (COPD) and lung cancer are devastating pulmonary
diseases that commonly coexist and present a number of clinical challenges. COPD confers …

Chronic obstructive pulmonary disease is the 3rd leading cause of death worldwide. It not
only affects current and former smokers, but non-smokers as well. Chronic inflammatory …

Background COPD is an important comorbidity of lung cancer, but the impact of COPD on
the outcomes of lung cancer remains uncertain. Because both COPD and lung cancer are …

Inhaled corticosteroids (ICSs) are often prescribed in patients with chronic obstructive
pulmonary disease (COPD). Their impact on the risk of lung cancer, a leading cause of …

Chronic obstructive pulmonary disease (COPD) and lung cancer are common global causes
of morbidity and mortality. Because both diseases share several predisposing risks, the 2 …

COPD is a common and highly destructive disease with huge impacts on people and health
services throughout the world. It is mainly caused by cigarette smoking though …

Background COPD patients have an increased risk of developing lung cancer, but the
underlying mechanisms are poorly understood. We aimed to identify risk factors for lung …

Background Studies exploring the association between chronic obstructive pulmonary
disease (COPD) and lung cancer have yielded mixed results. We conducted a meta …

Background Inhaled corticosteroids (ICS) are suggested for potential chemoprevention of
lung cancer. Several observational studies in patients with chronic obstructive pulmonary …

Inhaled corticosteroids (ICS) might reduce the risk of lung cancer by controlling airway
inflammation in patients with chronic obstructive pulmonary disease (COPD) because both …